BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
27866 results:

  • 1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
    Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
    Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, cancer, and Type 2 Diabetes Mellitus.
    Agam G; Atawna B; Damri O; Azab AN
    Cells; 2024 May; 13(10):. PubMed ID: 38786025
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Maternal and Perinatal Factors Associated With Childhood brain Tumors: A Case-Control Study in Vietnam.
    Pham HN; Goldberg RJ; Pham LQ; Nguyen HL; Pham DA; Mai LTT; Phung TL; Hung DQ; Dong HV; Duong HD
    Cancer Control; 2024; 31():10732748241258602. PubMed ID: 38783766
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nutritional status and clinical outcomes of brain tumor surgery in pediatric intensive care unit: A prospective cohort study.
    Dadashi-Noshahr Y; Behzad A; Ahmadizadeh SN; Amirjani S; Vahdat Shariatpanahi Z
    Clin Nutr ESPEN; 2024 Jun; 61():302-307. PubMed ID: 38777448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost of Healthcare Services in Geriatric Neuro-oncology: A descriptive Analysis.
    Al-Siyabi ZS; Al-Mahrouqi O; Al-Senani O; Al-Amri S; Al-Ajmi Z; Al-Nazwani A; Taheri F; Al-Hashimi H; Al-Sheriyani M; Al-Ani MT; Al-Shamli SA; Al-Abri S; Al-Saadi T
    Gulf J Oncolog; 2024 May; 1(45):42-48. PubMed ID: 38774932
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
    Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
    Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical presentation and surgical outcomes of very large and giant pituitary adenomas: 80 cases in a cohort study of 306 patients with pituitary adenomas.
    Pascual-Corrales E; Acitores Cancela A; Baonza G; Madrid Egusquiza I; Rodríguez Berrocal V; Araujo-Castro M
    Acta Neurochir (Wien); 2024 May; 166(1):225. PubMed ID: 38772927
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of two region-of-interest placement methods for histogram analysis of apparent diffusion coefficient maps for glioma grading.
    Hieu ND; Hung ND; Hung ND; Hien MM; Anh DV; Dung LT
    Clin Ter; 2024; 175(3):128-136. PubMed ID: 38767069
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of the clinical use of MGMT methylation in extracellular vesicle-based liquid biopsy as a tool for glioblastoma patient management.
    Rosas-Alonso R; Colmenarejo-Fernández J; Pernía O; Burdiel M; Rodríguez-Antolín C; Losantos-García I; Rubio T; Moreno-Velasco R; Esteban-Rodríguez I; Martínez-Marín V; Yubero P; Costa-Fraga N; Díaz-Lagares A; López-López R; Díaz-Martin E; García JF; Sánchez CV; Gandía-González ML; Moreno-Bueno G; de Castro J; de Cáceres II
    Sci Rep; 2024 May; 14(1):11398. PubMed ID: 38762534
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Investigating the role of TGF-β and BDNF in cancer-related depression: a primary cross-sectional study.
    Lin J; Xiao L; Nie X; Wang Z; Luo Y; Zhang L; Liu Y
    Support Care Cancer; 2024 May; 32(6):365. PubMed ID: 38758235
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
    Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
    Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
    Ji Q; McAfee SS; Scoggins M; Holtrop J; Glass JO; Yuan X; Liang J; Li Y; Chiang J; Orr BA; Edwards A; Storment D; Brinkman T; Robinson GW; Gajjar A; Reddick WE; Patay Z; Khan RB; Bag AK
    Radiology; 2024 May; 311(2):e232521. PubMed ID: 38742969
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ultrasensitive and Rapid Circulating Tumor DNA Liquid Biopsy Using Surface-Confined Gene Amplification on Dispersible Magnetic Nano-Electrodes.
    Park BC; Soh JO; Choi HJ; Park HS; Lee SM; Fu HE; Kim MS; Ko MJ; Koo TM; Lee JY; Kim YK; Lee JH
    ACS Nano; 2024 May; 18(20):12781-12794. PubMed ID: 38733343
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Understanding supported self-management for people living with a lower-grade glioma: Implementation considerations through the lens of normalisation process theory.
    Rimmer B; Finch T; Balla M; Dutton L; Williams S; Lewis J; Gallagher P; Burns R; Araújo-Soares V; Menger F; Sharp L;
    Health Expect; 2024 Jun; 27(3):e14073. PubMed ID: 38733245
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
    Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
    Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1394.